帕金森病脑深部电刺激术后的长期结局
该研究回顾性分析了1999至2007年在本机构接受脑深部电刺激(DBS)植入的首批400例连续患者中的320例帕金森病(PD)患者,采用Kaplan-Meier法和Cox比例风险模型分析生存情况,并通过电话调查了解长期结局。结果显示,随访至少10年的患者10年生存概率为51%,DBS未能阻止疾病进展,但可提供持久的症状缓解并维持部分日常生活活动能力,患者满意度高。
要点
- 随访至少10年的患者10年生存概率为51%,死亡时平均年龄73岁
- 植入时年龄(HR 1.02,p=0.01)和男性(HR 1.42,p=0.02)与生存期缩短相关
- 电话调查中92.5%患者对DBS满意,95%愿意推荐DBS
核心结论
- 作者认为,DBS治疗PD与51%的10年生存率相关;调查数据提示DBS虽不能阻止PD疾病进展,但在超过10年的长期随访中提供持久的症状缓解并使许多患者维持日常生活活动能力,且患者满意度长期保持较高水平。
研究设计与样本
- 作者开展回顾性分析,利用本机构病历资料识别1999至2007年在本机构接受DBS植入的首批400例连续患者,其中帕金森病患者320例。
- 采用Kaplan-Meier估计进行生存分析,并采用Cox比例风险模型进行多因素回归,通过电话调查确定长期结局。
主要发现
- 帕金森病队列(n=320)平均年龄61岁,70%为男性,27%的患者至少有1种内科合并症(冠状动脉疾病、充血性心力衰竭、糖尿病、心房颤动或深静脉血栓)。
- 在随访至少10年的患者子集(n=200)中,Kaplan-Meier生存分析显示生存概率为51%,死亡时平均年龄73岁。
- 多因素回归显示,植入时年龄(HR 1.02,p=0.01)和男性(HR 1.42,p=0.02)可预测生存期缩短;内科合并症数量与生存无显著关联(p > 0.5)。
- 完成电话调查的40例存活患者平均年龄55.1 ± 6.4岁,72.5%为男性,95%接受丘脑底核DBS,平均随访13.0 ± 1.7年;震颤对DBS反应最好(72.5%的患者改善),其他运动症状保持稳定。
- 日常生活活动能力保持稳定(穿衣,78%的患者;跑腿办事,52.5%的患者)或恶化(做饭,50%的患者);患者满意度仍然很高(92.5%对DBS满意,95%愿意推荐DBS,75%认为DBS提供了症状控制)。
临床怎么用
- 作者认为,DBS治疗PD与51%的10年生存率相关,调查数据提示DBS不能阻止PD疾病进展,但可在超过10年的长期随访中提供持久的症状缓解并使许多患者维持日常生活活动能力,患者满意度长期保持较高水平。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep brain stimulation (DBS) is an effective treatment for several movement disorders, including Parkinson's disease (PD). While this treatment has been available for decades, studies on long-term patient outcomes have been limited. Here, the authors examined survival and long-term outcomes of PD patients treated with DBS. METHODS: The authors conducted a retrospective analysis using medical records of their patients to identify the first 400 consecutive patients who underwent DBS implantation at their institution from 1999 to 2007. The medical record was used to obtain baseline demographics and neurological status. The authors performed survival analyses using Kaplan-Meier estimation and multivariate regression using Cox proportional hazards modeling. Telephone surveys were used to determine long-term outcomes. RESULTS: Demographics for the cohort of patients with PD (n = 320) were as follows: mean age of 61 years, 70% male, 27% of patients had at least 1 medical comorbidity (coronary artery disease, congestive heart failure, diabetes mellitus, atrial fibrillation, or deep vein thrombosis). Kaplan-Meier survival analysis on a subset of patients with at least 10 years of follow-up (n = 200) revealed a survival probability of 51% (mean age at death 73 years). Using multivariate regression, the authors found that age at implantation (HR 1.02, p = 0.01) and male sex (HR 1.42, p = 0.02) were predictive of reduced survival. Number of medical comorbidities was not significantly associated with survival (p > 0.5). Telephone surveys were completed by 40 surviving patients (mean age 55.1 ± 6.4 years, 72.5% male, 95% subthalamic nucleus DBS, mean follow-up 13.0 ± 1.7 years). Tremor responded best to DBS (72.5% of patients improved), while other motor symptoms remained stable. Ability to conduct activities of daily living (ADLs) remained stable (dressing, 78% of patients; running errands, 52.5% of patients) or worsened (preparing meals, 50% of patients). Patient satisfaction, however, remained high (92.5% happy with DBS, 95% would recommend DBS, and 75% felt it provided symptom control). CONCLUSIONS: DBS for PD is associated with a 10-year survival rate of 51%. Survey data suggest that while DBS does not halt disease progression in PD, it provides durable symptomatic relief and allows many individuals to maintain ADLs over long-term follow-up greater than 10 years. Furthermore, patient satisfaction with DBS remains high at long-term follow-up.
引用
- Hitti FL, Ramayya AG, McShane BJ, et al. Long-term outcomes following deep brain stimulation for Parkinson's disease. J Neurosurg. 2019. PMID: 30660117. doi:10.3171/2018.8.JNS182081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。